These pathways include the activated p38 mitogen-activated protein kinase (p38MAPK), overactivated JAK-STAT, promoted ERK and AKT, or reduced phosphatase and TENsin homolog (PTEN), acting as tumor suppressors [193–195]. The gene discussed is AKT1; the disease is neoplasm.